Basics Xencor, Inc. Xencor Inc is engaged in the field of biotechnology. The United States-based firm develops drugs to combat severe diseases such as allergies and cancers. IPO Date: December 3, 2013 Sector: Healthcare Industry: Biotech Market Cap: $610.65M Activated in VL: True Average Daily Range Avg Daily Range: $0.56 | 2.29% Avg Daily Range (30 D): $0.31 | 3.40% Avg Daily Range (90 D): $0.34 | 3.16% Institutional Daily Volume Avg Daily Volume: .26M Avg Daily Volume (30 D): .79M Avg Daily Volume (90 D): .64M Trade Size Avg Trade Size (Sh.): 69 Avg Trade Size (Sh.) (30 D): 70 Avg Trade Size (Sh.) (90 D): 63 Institutional Trades Total Inst.Trades: 2,928 Avg Inst. Trade: $2M Avg Inst. Trade (30 D): $1.41M Avg Inst. Trade (90 D): $1.55M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.27M Avg Closing Trade (30 D): $1.41M Avg Closing Trade (90 D): $1.7M Avg Closing Volume: 82.86K     News Sep 12, 2024 @ 5:09 PM Xencor Surges 10.5%: Is This an Indication of Furt... Source: Zacks Jun 14, 2024 @ 6:00 PM Peeling Back The Layers: Exploring Xencor Through ... Source: Benzinga Insights May 10, 2024 @ 7:00 PM Decoding 6 Analyst Evaluations For Xencor Source: Benzinga Insights May 6, 2024 @ 2:00 PM Xencor (XNCR) Expected to Beat Earnings Estimates:... Source: Zacks Equity Research May 2, 2024 @ 9:45 PM Ardelyx (ARDX) Reports Q1 Loss, Tops Revenue Estim... Source: Zacks Equity Research Financials   TTM Q1 2025 Q3 2024 Basic EPS $-.66 $-.71 Diluted EPS $-.66 $-.71 Revenue $ $ 32.73M $ 10.71M Gross Profit $ $ $ Net Income / Loss $ $ -48.63M $ -46.3M Operating Income / Loss $ $ -43.18M $ -62.28M Cost of Revenue $ $ $ Net Cash Flow $ $ -1.3M $ -1.74M PE Ratio